Cost-effectiveness of aromatase inhibitors versus selective estrogen-receptor modulators for breast cancer prevention in postmenopausal women.
Amy Grace Groom
No relevant relationships to disclose
Chris Skedgel
No relevant relationships to disclose
Daniel Rayson
No relevant relationships to disclose
Tallal Younis
No relevant relationships to disclose